Sandoz TV Episode 18: Trailer
Find out what to expect from the newest episode of Sandoz TV.
|Global News||Sandoz Around the World||Sandoz in the Media|
Sandoz Poland celebrates the opening of a new packaging plant in Stryków
Stryków, May 07, 2015
Sandoz, the generic Division of Novartis is announcing today the opening of the Sandoz Packaging Centre in Stryków – a project valued at 171 million PLN.
Novartis Q1 Results 2015
Basel, April 23, 2015
Novartis delivered sales growth (cc), significant margin expansion (cc) and strong innovation in Q1; now with a more focused portfolio
Sandoz receives FDA approval for Glatopa™ as the first generic competitor to MS therapy Copaxone® 20mg
Holzkirchen, Germany, April 16, 2015
Sandoz, a Novartis company, today announced the US approval of GlatopaTM, the first generic version of Teva’s Copaxone® (glatiramer acetate injection) 20 mg/ml one-time-daily multiple sclerosis therapy.
Innovative respiratory inhaler Airflusal® Forspiro® receives Alufoil Trophy 2015
April 16, 2015
AirFluSal® Forspiro®, an innovative respiratory inhaler from Sandoz, has won the coveted Alufoil Trophy 2015 in the Product Preservation category.
Sandoz launches authorized generic version of EXFORGE® in the US
Princeton, New Jersey, March 31, 2015
Sandoz today announced the US market introduction of amlodipine and valsartan combination tablets, a generic version of EXFORGE® made by Novartis.